tetano
Editor, Senior Moderator
Scand J Gastroenterol
. 2021 Feb 16;1-5.
doi: 10.1080/00365521.2021.1881814. Online ahead of print.
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019
Mohamed Attauabi[SUP] 1 2 [/SUP], Johan Burisch[SUP] 1 2 [/SUP], Flemming Bendtsen[SUP] 1 2 [/SUP], Nina Kimer[SUP] 1 3 [/SUP]
Affiliations
Abstract
Objectives: Coronavirus disease 2019 (COVID-19) is an ongoing major health emergency, but its occurrence and clinical impact on patients withliver cirrhosis is unknown. Therefore, we conducted a population-based study of 2.6 million Danish citizens investigating the occurrence and impact of COVID-19 in patients with liver cirrhosis.
Materials and methods: A prospective population-based cohort study was conducted in the Capital Region of Denmark and Region Zealand in the study period between 1 March 2020 up until 31 May 2020, with the only eligibility criteria being a reverse-transcriptase polymerase chain reaction for presence of viral genomic material confirming COVID-19. The patients were subsequently stratified according to presence of pre-existing liver cirrhosis.
Results: Among 575,935 individuals tested, 1713 patients had a diagnosis of cirrhosis. COVID-19 occurredsignificantly lessamongpatients with cirrhosis (n = 15; 0.9%, p < .01) compared with the population without cirrhosis (n = 10,593; 1.8%). However, a large proportion (n = 6;40.0%) required a COVID-19 related hospitalization which was correlated with higher values of alanine aminotransferase (p < .01) and lactate dehydrogenase (p = .04). In addition, one-in-three (n = 2; 13.3%) required intensive therapy. Four patients died (26.7%) and mortality was associated with higher MELD scores, co-existing type 2 diabetes, and bacterial superinfections.
Conclusion: In conclusion, patientswith cirrhosis may have a lower risk of COVID-19; but a higher risk of complications hereto and mortality.
Keywords: COVID-19; acute-on-chronic liver failure; coronavirus disease 2019; disease course; epidemiology; infectious diseases; liver cirrhosis; mortality; population-based; superinfections.
. 2021 Feb 16;1-5.
doi: 10.1080/00365521.2021.1881814. Online ahead of print.
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019
Mohamed Attauabi[SUP] 1 2 [/SUP], Johan Burisch[SUP] 1 2 [/SUP], Flemming Bendtsen[SUP] 1 2 [/SUP], Nina Kimer[SUP] 1 3 [/SUP]
Affiliations
- PMID: 33590789
- DOI: 10.1080/00365521.2021.1881814
Abstract
Objectives: Coronavirus disease 2019 (COVID-19) is an ongoing major health emergency, but its occurrence and clinical impact on patients withliver cirrhosis is unknown. Therefore, we conducted a population-based study of 2.6 million Danish citizens investigating the occurrence and impact of COVID-19 in patients with liver cirrhosis.
Materials and methods: A prospective population-based cohort study was conducted in the Capital Region of Denmark and Region Zealand in the study period between 1 March 2020 up until 31 May 2020, with the only eligibility criteria being a reverse-transcriptase polymerase chain reaction for presence of viral genomic material confirming COVID-19. The patients were subsequently stratified according to presence of pre-existing liver cirrhosis.
Results: Among 575,935 individuals tested, 1713 patients had a diagnosis of cirrhosis. COVID-19 occurredsignificantly lessamongpatients with cirrhosis (n = 15; 0.9%, p < .01) compared with the population without cirrhosis (n = 10,593; 1.8%). However, a large proportion (n = 6;40.0%) required a COVID-19 related hospitalization which was correlated with higher values of alanine aminotransferase (p < .01) and lactate dehydrogenase (p = .04). In addition, one-in-three (n = 2; 13.3%) required intensive therapy. Four patients died (26.7%) and mortality was associated with higher MELD scores, co-existing type 2 diabetes, and bacterial superinfections.
Conclusion: In conclusion, patientswith cirrhosis may have a lower risk of COVID-19; but a higher risk of complications hereto and mortality.
Keywords: COVID-19; acute-on-chronic liver failure; coronavirus disease 2019; disease course; epidemiology; infectious diseases; liver cirrhosis; mortality; population-based; superinfections.